[Fabry disease: A review].
Michaud M, Mauhin W, Belmatoug N, Bedreddine N, Garnotel R, Catros F, Lidove O, Gaches F.
Rev Med Interne. 2021 Feb;42(2):110-119. doi: 10.1016/j.revmed.2020.08.019. Epub 2020 Nov 7.
A Review of Fabry Disease.
Chan B, Adam DN.
Skin Therapy Lett. 2018 Mar;23(2):4-6.
An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease.
Germain DP, Altarescu G, Barriales-Villa R, Mignani R, Pawlaczyk K, Pieruzzi F, Terryn W, Vujkovac B, Ortiz A.
Mol Genet Metab. 2022 Sep-Oct;137(1-2):49-61. doi: 10.1016/j.ymgme.2022.07.010. Epub 2022 Jul 26.
When and How to Diagnose Fabry Disease in Clinical Pratice.
Michaud M, Mauhin W, Belmatoug N, Garnotel R, Bedreddine N, Catros F, Ancellin S, Lidove O, Gaches F.
Am J Med Sci. 2020 Dec;360(6):641-649. doi: 10.1016/j.amjms.2020.07.011. Epub 2020 Jul 10.
Fabry disease: where are we now?
Turkmen K, Baloglu I.
Int Urol Nephrol. 2020 Nov;52(11):2113-2122. doi: 10.1007/s11255-020-02546-3. Epub 2020 Jul 13.
Fabry disease: genetics, pathology, and treatment.
Bernardes TP, Foresto RD, Kirsztajn GM.
Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s10-s16. doi: 10.1590/1806-9282.66.S1.10.
Fabry disease.
Schiffmann R.
Handb Clin Neurol. 2015;132:231-48. doi: 10.1016/B978-0-444-62702-5.00017-2.
Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations.
Izhar R, Borriello M, La Russa A, Di Paola R, De A, Capasso G, Ingrosso D, Perna AF, Simeoni M.
Genes (Basel). 2023 Dec 26;15(1):37. doi: 10.3390/genes15010037.
Fabry disease.
Toyooka K.
Handb Clin Neurol. 2013;115:629-42. doi: 10.1016/B978-0-444-52902-2.00037-0.
Biomarkers in Anderson-Fabry Disease.
Simonetta I, Tuttolomondo A, Daidone M, Pinto A.
Int J Mol Sci. 2020 Oct 29;21(21):8080. doi: 10.3390/ijms21218080.
